Founder of Blueprint. I help companies stop sending emails nobody wants to read.
The problem with outbound isn't the message. It's the list. When you know WHO to target and WHY they need you right now, the message writes itself.
I built this system using government databases, public records, and 25 million job posts to find pain signals most companies miss. Predictable Revenue is dead. Data-driven intelligence is what works now.
Your GTM team is buying lists from ZoomInfo, adding "personalization" like mentioning a LinkedIn post, then blasting generic messages about features. Here's what it actually looks like:
The Typical Onit SDR Email:
Why this fails: The prospect is an expert. They've seen this template 1,000 times. There's zero indication you understand their specific situation. Delete.
Blueprint flips the approach. Instead of interrupting prospects with pitches, you deliver insights so valuable they'd pay consulting fees to receive them.
Stop: "I see you're hiring compliance people" (job postings - everyone sees this)
Start: "Your Dallas litigation counsel bills $485/hour - that's 22% above the $398 median for similar matters" (proprietary benchmarking data only you have)
PQS (Pain-Qualified Segment): Reflect their exact situation with such specificity they think "how did you know?" Use public data with dates, record numbers, facility addresses, or proprietary insights from your customer base.
PVP (Permissionless Value Proposition): Deliver immediate value they can use today - analysis already done, deadlines already pulled, patterns already identified - whether they buy or not.
Company: Onit
Core Problem: Enterprise legal departments struggle to manage thousands of contracts, track compliance obligations, and control legal spending across the organization, leading to missed deadlines, budget overruns, and regulatory risks.
Target ICP: Large enterprises (5,000+ employees) in highly regulated industries including Financial Services, Healthcare, Energy, Pharmaceuticals, Manufacturing, and Technology. Organizations with complex contract portfolios (500+ active contracts), significant outside counsel spend ($5M+), and need for centralized legal operations across multiple jurisdictions.
Primary Buyer Persona: General Counsel, Chief Legal Officer, VP of Legal Operations - responsible for managing outside counsel relationships and spend, contract lifecycle oversight, legal process efficiency, budget management, and cross-functional stakeholder coordination.
These messages demonstrate precise understanding of the prospect's current situation and deliver immediate actionable value. Ordered by quality score (highest first).
Cross-reference internal contract expiration tracking with FDA OAI classification timeline to identify supplier quality agreements expiring before re-inspection. Deliver a pre-built, prioritized list organized by criticality.
This is pure value delivery - you've already done hours of manual tracking and prioritization work they would need to do anyway. The specificity (18 agreements, exact re-inspection window, organized by criticality) proves you understand FDA remediation requirements. No ask, just value.
This play requires the recipient's contract data from your system - supplier quality agreements, expiration dates, and criticality categorization.
Only works for upselling existing customers, not cold acquisition. The value is in synthesizing their internal contract data with external FDA timelines.Filter all Q1 contract renewals to surface only the highest-value agreements where the vendor had recent C-suite turnover. Provide complete package with new executive names and LinkedIn profiles for relationship mapping.
Legal operations teams are drowning in renewals. You've pre-filtered to the 5 highest-risk contracts and done the executive research legwork. This saves them hours and helps them prioritize relationship management during leadership transitions. The offer to provide LinkedIn profiles shows you've already done the work.
This play requires the recipient's contract portfolio from your system - renewal dates, contract values, and vendor names.
Only works for existing customers. The value is correlating their internal renewal pipeline with external executive transition signals.Identify specific supplier quality agreements expiring between OAI classification and estimated re-inspection window. Surface the timing risk with exact dates and FDA inspection implications.
The synthesis of internal contract dates with external FDA re-inspection timing creates genuine strategic value. FDA inspectors specifically verify current supplier agreements during OAI remediation reviews. The specificity (exact supplier name, exact expiration date, exact re-inspection window) proves deep understanding of both their contracts and FDA compliance requirements.
This play requires the recipient's supplier agreement data from your contract system - specific suppliers, agreement types, and expiration dates.
Only works for existing customers. The value is in connecting their internal contract timeline with external FDA re-inspection requirements.Identify pattern across multiple high-value contracts all renewing during vendor C-suite transitions. The clustering of leadership changes across multiple vendors creates compounded risk and urgency.
One contract renewal during leadership change is notable. THREE contracts totaling $8.4M all facing the same timing issue is a genuine strategic problem requiring prioritization. The pattern recognition shows you're monitoring their entire vendor portfolio, not just cherry-picking one contract. Offers immediate actionable list.
This play requires the recipient's contract renewal pipeline from your system - specific contracts, values, and vendor names for Q2 2025.
Only works for existing customers. The pattern recognition across their vendor portfolio is the value.Correlate public FDA OAI classification with internal contract expiration data to identify supplier quality agreements expiring during remediation period. Surface the compliance risk with exact dates and regulatory context.
The synthesis is genuinely valuable - combining their internal contract timeline with external FDA enforcement creates strategic timing insight they might miss. Specific facility name, exact OAI date, exact agreement count, and direct FDA compliance connection demonstrates deep understanding of pharmaceutical quality requirements.
This play requires the recipient's supplier quality agreement data from your contract system with expiration tracking.
Only works for existing customers. The value is connecting their internal contract data with external FDA enforcement timeline.Use aggregated e-billing data across 200+ technology company clients to benchmark the prospect's IP litigation counsel rates. Provide specific rate comparison, annual spend, and calculated savings opportunity.
References large dataset (200+ companies) to establish credibility. Shows exact rate overpayment percentage, their actual annual spend, and calculated potential savings. This is proprietary benchmarking data they cannot get elsewhere. The specificity makes it immediately actionable for rate negotiations.
This play requires aggregated e-billing rate data across 200+ technology company clients, categorized by matter type (IP litigation) with median and percentile benchmarks.
This is proprietary data only Onit has - competitors cannot replicate this play. Works for new customer acquisition because YOU have the benchmark data.Identify high-value service agreements with auto-renewal dates occurring during vendor CEO transitions. Surface the timing risk with exact contract value, renewal date, and executive departure timeline.
The synthesis of internal contract timeline with external executive transition creates genuine strategic insight. New CEOs often review major vendor relationships in first 90 days. The specificity (exact contract value, exact dates, exact executive departure timing) demonstrates you're tracking both their contracts and their vendors' leadership changes.
This play requires the recipient's contract data from your system - specific service agreements, renewal dates, and contract values.
Only works for existing customers. The value is correlating their internal renewal timeline with external vendor leadership changes.Old way: Spray generic messages at job titles. Hope someone replies.
New way: Use proprietary benchmarking data and public regulatory signals to find legal departments in specific painful situations. Then deliver insights they can't get elsewhere.
Why this works: When you lead with "Your IP litigation counsel bills 18% above the $440/hour median we see across 200+ tech companies" instead of "I see you're hiring legal operations people," you're not another sales email. You're the person with data they need for their next rate negotiation.
The messages above aren't templates. They're examples of what happens when you combine proprietary customer data (e-billing benchmarks, contract renewal tracking) with public regulatory signals (FDA OAI classifications, executive transitions). Your team can replicate this using the data sources in each play.
Every play traces back to verifiable data. Here are the sources used in this playbook:
| Source | Key Fields | Used For |
|---|---|---|
| Onit E-Billing System | Outside counsel rates, matter type, annual spend, practice area, jurisdiction | IP Litigation Rate Benchmarking |
| Onit Contract System | Renewal dates, contract values, counterparty names, agreement types, expiration tracking | Contract Renewal Risk Alerts, Supplier Agreement Tracking |
| FDA Inspection Classification Database | OAI classification dates, facility names, establishment addresses, inspection dates | OAI Remediation Timeline Tracking |
| LinkedIn Executive Movement | C-suite transitions, announcement dates, new roles, company changes | Vendor Leadership Change Monitoring |
| SEC 8-K Filings | Executive departure announcements, organizational restructuring, material events | Public Company Leadership Transitions |
| FDA Form 483 Database | Common observations, supplier oversight citations, remediation requirements | Compliance Risk Context |